Analyst Ratings for Iterum Therapeutics (ITRM)

ITRM Rating Summary

ITRM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ITRM
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $2.25 (+118.4%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/15/2021 H.C. Wainwright Ed Arce Upgrade Buy
(Neutral)
2.50
(N/A)
1.55
(1.03)
-33.55% Details
6/2/2020 RBC Capital Gregory Renza Downgrade Sector Perform
(Outperform)
2.00
(7.00)
4.21
(1.03)
-75.53% Details
Like ITRM Ratings? Also take a look at SMMT, XERS, PRTK, NEOS

ITRM Ratings News